Syros tyme technologies
WebJun 28, 2024 · TYME (Nasdaq: TYME), an innovative biotechnology company leveraging novel and data-driven approaches to develop therapeutics for difficult to treat cancers. Science & Technology Bedminster, NJ 07921 tymeinc.com Joined June 2024. 1,200 Following. 1,157 Followers. WebJul 5, 2024 · Syros is redefining the power of small molecules to control the expression of genes. Based on its unique ability to elucidate regulatory regions of the genome, Syros …
Syros tyme technologies
Did you know?
WebJul 5, 2024 · (RTTNews) - Syros Pharmaceuticals (SYRS) and TYME Technologies, Inc. (TYME) announced that the companies have entered into a definitive merger agreement pursuant to which Syros will... WebJul 5, 2024 · (RTTNews) - Syros Pharmaceuticals (SYRS) and TYME Technologies, Inc. (TYME) announced that the companies have entered into a definitive merger agreement …
WebJul 5, 2024 · Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement July 5, 2024, 7:00 AM · 16 min read Combined Company Will Operate as Syros... WebWho is Tyme Technologies Headquarters 1 Pluckemin Way Ste 103, Bedminster, New Jersey, 07921, United States Phone Number (212) 461-2315 Website www.tymeinc.com Revenue $27.5M Stock Symbol TYME Industry Business Services General Business Services Tyme Technologies's Social Media Is this data correct? View contact profiles from Tyme …
WebApr 10, 2024 · Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals, Inc. … WebAt Syros, we have identified cancer patients with aberrant expression of genes that can be targeted with new therapies. We are focused on applying this approach to developing new …
WebJul 5, 2024 · Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement Business Wire July 5, 2024, 4:00 AM · 16 …
WebNov 14, 2024 · In September, Syros announced the closing of its merger with TYME Technologies, pursuant to which Syros acquired TYME, including its pipeline assets and net cash at closing of approximately $60 million. Concurrent with the closing of the merger, Syros also closed the previously announced oversubscribed $130 million private … irony vocloid japanese coverWebJul 5, 2024 · Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement SYRS July 5, 2024 Combined Company Will Operate as Syros Pharmaceuticals and Continue to Advance Syros’ Ongoing Clinical Programs Syros Expects to Have Cash Into 2025; At Least a Year Past SELECT-MDS-1 … irony websiteWebJul 5, 2024 · In the merger, Syros expects to issue approximately 74.3 million shares of its common stock to TYME stockholders to acquire TYME’s expected net cash at closing and … portable air conditioner hammacher schlemmerWebSep 15, 2024 · Shareholders of Syros Pharmaceuticals (SYRS) and Tyme Technologies (TYME) on Thursday voted in favor of the merger between the two biotech companies.SYRS and TYME stock gained more... portable air conditioner for garageWebSep 15, 2024 · CAMBRIDGE, Mass. and BEDMINSTER, N.J., Sept. 15, 2024 (GLOBE NEWSWIRE) -- Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, and Tyme Technologies, Inc. (NASDAQ:TYME) today announced the results of the special meetings of the stockholders … irony what isWebSep 15, 2024 · Shareholders of Syros Pharmaceuticals ( NASDAQ: SYRS) and Tyme Technologies ( NASDAQ: TYME) on Thursday voted in favor of the merger between the … irony where is thy stingWebJul 5, 2024 · Rare Daily Staff Syros Pharmaceuticals, a company focused on the development of medicines that control the expression of genes will acquire Tyme Technologies, a company developing cancer metabolism-based therapies with low toxicity profiles. Syros will acquire Tyme’s assets and net cash at closing, which after accounting … irony will betray you in the end